SCHEMBL9489202

SCHEMBL9489202

CCOC(=O)N(CC(=O)O)C(=O)c1c(F)ccc2c(C(F)(F)F)c(OC)ccc12

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 1/20 0.48
AKR1A1 P14550 1/20 0.48
AKR1B1 P15121 1/20 0.48
PRKCZ Q05513 1/20 0.33
KCNN4 O15554 1/20 0.33
CDC25B P30305 1/20 0.32
PTGDR2 Q9Y5Y4 5/20 0.31
CYP2C9 P11712 2/20 0.31
CYP3A4 P08684 1/20 0.31
TBXA2R P21731 1/20 0.31
PTGIR P43119 1/20 0.31
PTGDR Q13258 1/20 0.31
MEN1 O00255 2/20 0.31
ALDH1A1 P00352 2/20 0.31
KMT2A Q03164 2/20 0.31
LMNA P02545 1/20 0.31
DPP4 P27487 1/20 0.31
PDE6D O43924 1/20 0.30
PDE5A O76074 1/20 0.30
PDE6A P16499 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9489016 0.90 AKR1B10 (0.50) AKR1B10AKR1A1AKR1B1KCNN4PTGDR2
SCHEMBL9490667 0.90 AKR1B10 (0.46) AKR1B10AKR1A1AKR1B1CDC25BMEN1
SCHEMBL9489172 0.90 AKR1B10 (0.46) AKR1B10AKR1A1AKR1B1CDC25BPTGDR2
SCHEMBL9491073 0.89 AKR1B10 (0.46) AKR1B10AKR1A1AKR1B1CDC25BCYP2C9
SCHEMBL10415834 0.84 AKR1B10 (0.62) AKR1B10AKR1A1AKR1B1CDC25BCYP2C9
SCHEMBL9489702 0.82 AKR1B10 (0.61) AKR1B10AKR1A1AKR1B1CYP2C9LMNA
SCHEMBL9490893 0.81 AKR1B10 (0.42) AKR1B10AKR1A1AKR1B1KCNN4CYP2C9
SCHEMBL7600139 0.80 AKR1B10 (0.42) AKR1B10AKR1A1AKR1B1CDC25BMEN1
SCHEMBL9489025 0.80 AKR1B10 (0.48) AKR1B10AKR1A1AKR1B1PTGDR2CYP2C9
SCHEMBL9489492 0.80 AKR1B10 (0.48) AKR1B10AKR1A1AKR1B1PTGDR2TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0322256-B1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1993-03-24 EP claimed
WO-1989005793-A1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-29 WO claimed
EP-0322256-A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-28 EP claimed
US-4820727-A TREATING DIABETIC COMPLICATIONS-VISION DEFECTS, KIDNEY AND NERVOUS SYSTEM DISORDERS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-04-11 US claimed
EP-0322256-B1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1993-03-24 EP disclosed
WO-1989005793-A1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-29 WO disclosed
EP-0322256-A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-28 EP disclosed
US-4820727-A TREATING DIABETIC COMPLICATIONS-VISION DEFECTS, KIDNEY AND NERVOUS SYSTEM DISORDERS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-04-11 US disclosed